Market closed
Inotiv/$NOTV
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Inotiv
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.
Ticker
$NOTV
Sector
Trading on
Industry
Life Sciences Tools & Services
Headquarters
Employees
2,026
Website
Inotiv Metrics
BasicAdvanced
$100M
Market cap
-
P/E ratio
-$4.19
EPS
3.64
Beta
-
Dividend rate
Price and volume
Market cap
$100M
Beta
3.64
52-week high
$11.42
52-week low
$1.23
Average daily volume
1.2M
Financial strength
Current ratio
1.373
Quick ratio
0.798
Long term debt to equity
252.083
Total debt to equity
261.063
Interest coverage (TTM)
-1.84%
Management effectiveness
Return on assets (TTM)
-6.59%
Return on equity (TTM)
-49.61%
Valuation
Price to revenue (TTM)
0.203
Price to book
0.59
Price to tangible book (TTM)
-0.5
Price to free cash flow (TTM)
-3.416
Growth
Revenue change (TTM)
-14.27%
Earnings per share change (TTM)
2.18%
3-year revenue growth (CAGR)
76.27%
3-year earnings per share growth (CAGR)
180.43%
What the Analysts think about Inotiv
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Inotiv stock.
Inotiv Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Inotiv Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Inotiv News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Inotiv stock?
Inotiv (NOTV) has a market cap of $100M as of December 21, 2024.
What is the P/E ratio for Inotiv stock?
The price to earnings (P/E) ratio for Inotiv (NOTV) stock is 0 as of December 21, 2024.
Does Inotiv stock pay dividends?
No, Inotiv (NOTV) stock does not pay dividends to its shareholders as of December 21, 2024.
When is the next Inotiv dividend payment date?
Inotiv (NOTV) stock does not pay dividends to its shareholders.
What is the beta indicator for Inotiv?
Inotiv (NOTV) has a beta rating of 3.64. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.